703 posters,  63 sessions,  7 topics,  1978 authors 
ePostersLive® by SciGen® Technologies S.A. All rights reserved.

4855
Intravenous Dexamethasone for Prolongation of Analgesia Following Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy: A Randomized, Controlled, Phase IV Dose-Response Study
Session: MP-05b
Fri, April 20, 8-9:30 am
Uris (Shubert Complex), 6th floor

Please note, medically challenging cases are removed three months after the meeting and scientific abstracts after three years.

Rate

No votes yet

Intravenous Dexamethasone for Prolongation of Analgesia Following Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy: A Randomized Controlled Study

Introduction

The optimal dose of intravenous (IV) dexamethasone for prolongation of analgesia from supraclavicular blocks in shoulder surgery has yet to be delineated (1-4). Many studies comparing IV to perineural dexamethasone have shown analgesic equivalence. Thus, this triple-blinded study aims to clarify the analgesic duration provided by supraclavicular blocks when supplemented with varying doses of IV dexamethasone and to clarify the effect of IV dexamethasone on blood glucose levels during and after arthroscopic surgery.

Materials and Methods

140 patients scheduled for ambulatory shoulder arthroscopy with supraclavicular blocks (30-40cc of 50:50 mixture 1.5% Mepivacaine:0.5% Bupivacaine) and sedation, were randomized into four groups to receive 0mg, 4mg, 6mg, or 8mg of IV dexamethasone.

The primary outcome was the analgesic duration defined as the time from block placement until the patient reported time that analgesia from the block completely wore off.  

Results

 

Patient characteristics are reported (Table 1). The median time until pain relief from the block completely wore off was 17.4 hours for the 0mg group, 22.7 hours for the 4mg group, 20.2 hours for the 6mg group and 19.8 hours for the 8mg group (Figures 1 and 2). Mean blood glucose levels for the 0mg, 4mg, 6mg and 8mg groups were 101.6 ± 20.2mg/dl, 124.5 ± 30.7mg/dl, 110.1 ± 22.8mg/dl, and 110.0 ± 27.1mg/dl at two hours after dexamethasone administration (Figure 3).  Postoperatively, one patient in the 8mg group developed a psoriatic rash at the site of a previously healed spider bite.

Discussion

 

There was no significant difference in block duration between any of the doses of IV dexamethasone and placebo. However, in a post-hoc analysis of the pooled dexamethasone groups, dexamethasone mildly increased the duration of analgesia compared to the saline group (20h vs. 17h, p=0.02). Patients in all groups reported excellent satisfaction with their analgesia.

References

 

1.Desmet M, Braems H, Reynvoet M, Plasschaert S, Van Cauwelaert J, et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled study. Br J Anaesth 2013; 111: 445-452.

 

2.Abdallah FW, Johnson J, Chan V, Murgatroyd H, Ghafari M, Ami N, Jin R, Brull R. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block: a randomized, triple-arm, double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2015;40:125-32.

 

3.Rosenfeld DM, Ivancic MG, Hattrup SJ, Renfree KJ, Watkins AR, Hentz JG, Gorlin AW, Spiro JA, Trentman. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia. 2016;71:380-8.

 

4.Chong MA, Berbenetz NM, Lin C, Singh S. Perineural Versus Intravenous Dexamethasone as an Adjuvant for Peripheral Nerve Blocks: A Systematic Review and Meta-Analysis. Reg Anesth Pain Med. 2017;42:319-326


Enter Poster ID (e.gGoNextPreviousCurrent